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The eukaryotic biological clock involves a negative
transcription-translation feedback loop in which
clock genes regulate their own transcription and
that of output genes of metabolic significance. While
around 10% of the liver transcriptome is rhythmic,
only about a fifth is driven by de novo transcrip-
tion, indicating mRNA processing is a major circa-
dian component. Here, we report that inhibition of
transmethylation reactions elongates the circadian
period. RNA sequencing then reveals methylation
inhibition causes widespread changes in the tran-
scription of the RNA processing machinery, associ-
ated with m6A-RNA methylation. We identify m6A
sites on many clock gene transcripts and show that
specific inhibition of m6A methylation by silencing
of the m6A methylase Mettl3 is sufficient to elicit
circadian period elongation and RNA processing
delay. Analysis of the circadian nucleocytoplasmic
distribution of clock genes Per2 and Arntl then
revealed an uncoupling between steady-state pre-
mRNA and cytoplasmic mRNA rhythms when m6A
methylation is inhibited.
INTRODUCTION
Themammalian circadian clock regulates metabolismmainly via
transcriptional control of clock output genes coding for master
metabolic switches or rate-limiting enzymes. Metabolism in turn
can adjust the clock, for example by modulating acetylation/de-
acetylation of histones on promoters activated by core clock pro-
tein complexCLOCK:ARNTL (Nakahata et al., 2008) or directly by
affecting acetylation status of PER proteins (Asher et al., 2008).
(De)acetylations, however, are only one of many possible
biochemical modifications that have the potential to link thecircadian clock with metabolism. Here, we focused on transme-
thylations, i.e., the addition of only one carbon (-CH3) to target
substrates.Unlike acetylation that only affects proteins, transme-
thylations are found at each step of the central dogma: DNA
methylation, RNA methylation, and protein methylation (histone
and nonhistone) have all been described (Carmel and Jacobsen,
2001). The role of histonemethylation for the function of the circa-
dian clock in mammals has recently been investigated (Katada
and Sassone-Corsi, 2010; Valekunja et al., 2013; Vollmers
et al., 2012). Similarly, the significance of the less dynamic DNA
CpG methylation for circadian clock inactivation during the
development of cancer and other diseases has been suggested
(Ripperger andMerrow, 2011). In contrast, the role of nonhistone
protein methylation and RNA methylation is unknown.
It has been known for many years that about 10% of genes are
rhythmic in the liver, driven by the circadian clock (Akhtar et al.,
2002). More recent RNA-sequencing data have shown that, of
these rhythmic genes, only about a fifth is driven by de novo tran-
scription (Koike et al., 2012). This observation has put regulation
of splicing and RNA processing at the forefront of biology since it
is not only significant for the function of the clock itself but also
how it regulates metabolism. In this light, RNA-methylation-
dependent RNA processing appears to be an interesting avenue.
All transmethylations, to various degrees, are influenced by
the metabolic state of the cell due to their sensitivity to the avail-
ability of S-adenosylmethionine (SAM), the universal methyl
donor cosubstrate, and to the relative amount of the its by-prod-
uct, S-adenosylhomocysteine (SAH), that acts as a competitive
inhibitor (Carmel and Jacobsen, 2001). The SAM/SAH ratio is
known as the ‘‘methylation potential.’’ Investigations into cellular
transmethylations have relied on the pharmacological inhibition
of SAH hydrolysis (Chiang, 1998). This inhibition leads to the
accumulation of SAH, the decrease of the methylation potential,
and ultimately to the inhibition of transmethylations.
To our knowledge, this approach has never been applied to the
investigation ofwhich transmethylations are needed for the circa-
dian clock function. Here, we report that the mammalian circa-
dian clock is exquisitely sensitive to the biochemical inhibitionCell 155, 793–806, November 7, 2013 ª2013 Elsevier Inc. 793
Figure 1. Global Methylation Inhibition Elongates the Circadian
Period in Peripheral Cell Types
(A) DAA dose dependently increases the period of PER2::LUC MEF. Traces
show mean of n = 2 dishes. Insert shows period analyzed by one-way
ANOVA and Bonferroni post hoc test, all significance p < 0.001 (mean ± SD,
n = 2).
(B) Same observations in human U2OS cells stably transfected with an Arntl-
luc reporter. Traces show mean of n = 2 dishes. Insert shows period analyzed
by one-way ANOVA and Bonferroni post hoc test, all significance p < 0.01
(mean ± SD, n = 2).
(C) MEFs and or U2OS cells were treated with 100 mM DAA or vehicle, Arntl
and Per2 gene expression was measured every 4 hr starting from 16 hr
post-DAA. Note the similar pattern obtained with luciferase reporters.
Data show mean ± SEM of n = 3 replicate dishes. See also Figure S1 and
Table S2.
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portional to the methylation potential. We discover in parallel
that transcriptional regulation of RNA processing machinery is
the main response to the global inhibition of transmethylations.
Focusing then on RNA processing, we reveal that specific inhibi-
tion of m6A-RNA methylation by knockdown of the methyltrans-
ferase Mettl3 is sufficient to elicit circadian period elongation
due to a decrease in RNA processing efficiency. The importance
ofRNA-methylation-dependentRNAprocessing for thecircadian
clock is then further demonstrated by inhibitingm7G-capmethyl-
ation and subsequent cap-binding complex association, which
also leads to period elongation.We therefore revealed the impor-
tance of epitranscriptomic regulation of the circadian clock.
RESULTS
Transmethylation Inhibition by 3-Deazaadenosine
Elongates the Circadian Period in Peripheral Cell Types
One of the most potent and frequently used SAH hydrolysis in-
hibitor is 3-deazaadenosine (DAA) (Chiang, 1998). We first tested
the effect of DAA on embryonic fibroblasts prepared from mice
(MEF) carrying a heterozygote fusion between the core clock
protein PER2 and luciferase (PER2::LUC, Figure 1A) and in hu-
man U2OS cells stably transfected with an Arntl-luc reporter
(Figure 1B). A dramatic increase of SAH induced by DAA, without
effect on methionine or S-adenosylmethionine, was confirmed
with PER2::LUC MEFs (Figure S1A available online). In both
cell types, DAA led to the elongation of the circadian period.
The expression of Per2 and Arntlmeasured directly was affected
by DAA in a manner consistent with real-time luminescence data
(Figure 1C). DAA dampened oscillations in MEF but not in U2OS.
No dramatic effects were observed on cell viability or prolifera-
tion, and the cells recovered completely from the influence of
DAA upon a medium change (Figures S1B, S1C, and S1D).
Period elongation in both cell types was also obtained with dea-
zaneplanocin A (DZnepA), a nonmetaboliseable carbocyclic
SAH hydrolysis inhibitor analog of DAA, confirming amechanism
dependent on methylation inhibition (Figure S1E). This demon-
strates that the mammalian circadian clock in peripheral cell
types is sensitive to the methylation potential collapse.
Transmethylation Inhibition Elongates the Locomotor
Activity Rhythm Period
To investigate whether the master mammalian circadian clock
that resides in the hypothalamic suprachiasmatic nucleus
(SCN) is also sensitive to global methylation inhibition, we treated
organotypic SCN slices prepared from Per1-luc reporter mice
with DAA (Figure 2A). In this system as well, DAA significantly
elongated the circadian period, suggesting a mechanism
conserved in both peripheral and master clocks.
Since the SCN controls rhythmic locomotor activity, we tested
DAA in mice by direct infusion into the third ventricle, above the
SCN, and recorded locomotor activity.Mice showed a significant
elongation of the activity rhythmperiod duringDAA infusion com-
pared to controls (CTL, 23.80 ± 0.08 hr; DAA, 24.88 ± 0.45 hr;
p < 0.01 in Bonferroni post hoc test after significant two-way
ANOVA; Figure 2B). This effectwas reversible, disappearing after
the delivery duration of the minipumps used (2 weeks).
Figure 2. The Circadian Master Clock in the Brain Is Sensitive to
Transmethylation Inhibition
(A) DAA increases the period of Per1-luc SCN slices. One representative slice
for CTL and DAA treatment is shown. Insert shows period analysis, a versus b
p < 0.001 in t test, n = 3, mean ± SEM.
(B) Brain DAA infusion (mice operated on the day indicated by brown triangles)
increases the locomotor activity rhythm period. Graph on the bottom: mean ±
SEM, analyzed in two-way ANOVA/Bonferroni analysis of n = 3 animals, with
** = p < 0.01. DD = constant darkness.Transcriptional Regulation of RNA Processing
Machinery Is a Major Response to DAA
To gain an insight into the mechanisms underlying period elon-
gation, we treated U2OS cells with DAA or vehicle for 24 hr to
avoid any potential acute effect of DAA, then analyzed the tran-
scriptome by RNA sequencing (Figure 3A). A total of 236,890
transcripts corresponding to 25,865 unique gene IDs were
detected. After filtering, 4,360 and 5,120 unique gene IDs were
respectively induced and inhibited by DAA (Figure 3B). DAA
had a complex effect on gene expression, since 9,480 genes
among 12,120 were significantly regulated. Gene ontology
(GO) analysis on the entire list of 9,480 single gene IDs, ranked
according to their p values, resulted in many nonspecific hits
(Figure 3C and Table S1). Interestingly, the 4th most significant
hit with highest Enrichment values (>8) was ‘‘rhythmic process,’’
containing clock-related genes such Per1, Per3, Dbp, Tef, and
Bhlhe41 (Table S1). This suggests that the circadian clock is
among the systems most sensitive to methylation inhibition,
but due to the breadth of the response to DAA this analysis did
not provide any mechanistic insights.
We then separately analyzed the 4,360 induced and the 5,120
repressed genes against the 9,480 significantly regulated genes
as background. The induced group showed an uncanny enrich-
ment in RNA metabolic processes (Figure 3C and Table S1).
The most significant match, RNA processing (GO:0006396), is
described as ‘‘any process involved in the conversion of one or
more primary RNA transcripts into one or moremature RNAmol-
ecules.’’ Among genes induced by DAA our data set included in
this GO term are, notably, the RNA m7G-cap methylases Rnmt
and Rnmt1l, as well as the m2
0-Oribose-cap methyltransferase
Ftsjd2; the m6A demethylase Alkbh5; other RNA methylases
such as Mettl2a, Mettl2b, and Rrp8; adenosine deaminases
such as Adar and Adat1; many other RNA-binding proteins such
as Ncbp2 and Rbms1; splicing factors such as Sf3a1 and Sf3a2.
The repressed gene group showed significant enrichments
mainly (three out of four) in processes related to translation due
to many ribosomal proteins and translation initiation factors
among downregulated genes (Figure 3C and Table S1). Together
this suggests that the transcriptional program of the RNA pro-
cessing machinery reacts to the global methylation inhibition by
DAA, maybe in an attempt to correct a deficient RNA-methyl-
ation-dependent processing. Supporting this hypothesis, RNA
methyltransferases are known to be the most sensitive to the
decrease of the methyl potential (Carmel and Jacobsen, 2001).
In particular, DAA is a strong inhibitor of the internal N6-Methyla-
denosine (m6A) (Backlund et al., 1986). Since the circadian
clock involves a transcription feedback loop, period elongation
via RNA-methylation-dependent RNA processing mechanisms
would be a thought-provoking and novel possibility.Cell 155, 793–806, November 7, 2013 ª2013 Elsevier Inc. 795
(legend on next page)
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Me-RIP Sequencing in U2OS Shows Transcriptome-
wide m6A Inhibition
To provide genome-wide information on which m6A methylation
sites in which transcripts are affected by DAA, the fragmented
mRNA from U2OS cells used above was used as input for
RNA immunoprecipitation with an anti-m6A antibody (Me-RIP,
Figure 3D). Our data revealed pervasive inhibition of m6Amethyl-
ation, since 2,293 transcripts from single gene IDs were
significantly regulated, containing 78% (1,789) of decreased
transcripts, as opposed to only 54% in the input. Per1, Per2,
Per3, Dbp, Nr1d1, and Nr1d2 transcripts show major methyl-
ation sites near the 30 end and in their longest internal exon,
confirming the pattern of m6A enrichment reported before (Dom-
inissini et al., 2012; Meyer et al., 2012). m6A sites were also
detected in the 30 regions of Clock, Nfil3, Tef, Bhlhe40, and
Bhlhe41, and in the 50 region ofArntl,Nr1d1, andPer3 (Figure S2).
Significant (p < 0.05) decrease in m6A methylation was detected
for Per1, Per3, Tef, Dbp, Nfil3, Bhlhe41, and Nr1d1 (Figure 3E).
The 504 transcripts with increased methylated peaks under
DAA treatment may appear startling, but 373 of these 504 tran-
scripts were also induced in the input. Plotting the fold induction
of all common 1,779 transcripts showing significant DAA/CTL
variations in the Me-RIP and the input revealed that transcripts
induced byDAA in the input consistently have a lower fold-induc-
tion ratio in the Me-RIP. This indicates DAA induces the tran-
scription of these genes but inhibits m6A methylation of their
mRNA (Figure 3F). In contrast, transcripts that are repressed
by DAA (<0.70-fold) in the input show correlated variations in
the Me-RIP.
DAA Treatment of MEFs Inhibits m6A Methylation and
Slows RNA Processing
The RNA-seq experiments above were performed with U2OS
cells, to allow comparison with other human cells (Dominissini
et al., 2012; Meyer et al., 2012). To investigate the consequent
mechanisms, we decided to shift to MEFs extracted from
PER2::LUC reporter mice. These knockin mice carry an insertion
of luciferase in phase with exon 23 of the Per2 gene (Yoo et al.,
2004), making them invaluable to follow Per2 mRNA or protein
processing in real-time. These cells were shown to respond to
DAA similarly to U2OS in Figure 1.
To confirm the inhibition of RNA methylation by DAA in these
cells, total RNA extracted fromMEFs treated with DAA or vehicle
for at least 24 hr was immunoprecipitated with the anti-m6A-RNA
antibody. In addition, we also used an anti-m7G-cap-RNA anti-
body to compare the effect of DAA on this methylation of theFigure 3. DAA triggers Changes in RNA Processing Machinery and Inh
(A) Experimental paradigm and methods.
(B) Scatter plot showing the genes significantly induced (pink) or repressed (turq
(C) Gene ontology analysis with all transcripts ranked according to p values (to
(bottom, turquoise). FDR = false discovery rate.
(D) Experimental paradigm of Me-RIP.
(E) Transcripts showing significant (p < 0.05) decrease in m6A methylated peaks.
red, Me-RIP from DAA-treated cells. Scale is provided on the top left of each tra
(F) Significant DAA/CTL-fold inductions of shared 1,779 transcripts between inpu
decreasing DAA/CTL ratio in the input. Genes induced by DAA in the input have d
by DAA correlate in the input and Me-RIP. Note Dbp, Tef, Per1, Per2, Nr1d1, and
consistent with top GO analysis at C. See also Figure S2 and Table S1.cap. Moreover, to investigate the possibility that RNA methyl-
ation shows time-dependent variations, we also measured
m6A methylation every 4 hr across 24 hr, starting from 24 hr
post-DAA. Per1, Per2,Dbp, and Arntl transcripts were quantified
in the immunoprecipitated (methylated RNA) and supernatant
(unmethylated) fractions, and the ratio between the two was
calculated (Figure 4A). For these transcripts, the m6A methyl-
ated/unmethylated mRNA ratio was significantly lower under
DAA, but the m7G-cap methylation ratio was not affected and
no consistent time-dependent differences in methylation in
these transcripts were detected. While the resistance of m7G-
cap methylation to DAA has been previously reported (Backlund
et al., 1986), we can’t reject the possibility that cotranscriptional
cap methylation was also inhibited by DAA, causing uncapped
pre-mRNA degradation (Jiao et al., 2013). These results none-
theless demonstrate that steady-state mRNA m6A methylation,
but not m7G-cap methylation, was inhibited by DAA in MEFs.
Next, we monitored RNA processing dynamics by pulse-
chase total RNA labeling click cytochemistry. MEFswere labeled
with ethynyl uridine for 2 hr then washed before treatment with
100 mM DAA or vehicle. DAA delayed RNA processing, as evi-
denced by the prolonged nuclear labeling intensity (Figure 4B),
even when de novo transcription was blocked by actinomycin
D (Figure S3A). To confirm these observations with mRNA-spe-
cific information, we treated cells with 100 mM DAA or control,
then quantified Arntl and Per2 mRNA from the cytoplasmic or
nuclear fractions extracted after 0, 2, and 4 hr post-DAA (Fig-
ure 4C). These results reveal DAA caused a relative increase in
the nuclear mRNA fraction, which was significant for Arntl at 2
and 4 hr post-DAA and at 4 hr post-DAA for Per2. Arntl was
very sensitive to DAA since at 2 hr the nuclear mRNA content
increased despite a reduction in steady-state pre-mRNA and
in cytoplasmic mRNA (Figure S3B). Arntl and Per2 steady-state
pre-mRNA levels were both strongly reduced under DAA treat-
ment (Figure 4C). The efficiency of our fractionation was checked
by quantifying the levels of a mitochondrial genome-encoded
transcript, and by measuring Per2 pre-mRNA concentration in
both fractions (Figure S3B).
It has been reported previously that Per2 mRNA degradation
rate is controlled in a circadian manner and is higher during the
waning phase of Per2 expression (Woo et al., 2009). We there-
fore surmise that if the period elongation elicited by DAA is
indeed caused by slower RNA processing, the delay would
occur mostly in the waning of Per2. Moreover, to compare the
respective effects of DAA on RNA processing and those of the
transcriptional elongation inhibitor actinomycin D, we treatedibits m6A-RNA Methylation
uoise) by DAA in the input.
p, blue), with only induced genes (middle, pink) or with only repressed genes
Blue, input RNA from CTL-treated cells; green, Me-RIP from CTL-treated cells;
ck.
t (blue) and Me-RIP samples (green). Transcripts are sorted along the x axis in
ecreased fold-induction in the Me-RIP, while fold induction of genes repressed
Bhlhe41 among the most downregulated genes both in the input and Me-RIP,
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Figure 4. DAA Inhibits Transcription and Delays mRNA Nuclear Export
(A) Treatment of MEFs with 100 mM DAA inhibits m6A-RNA methylation of all clock gene transcripts investigated (analyzed in two-way ANOVA/Bonferroni, CTL
versus DAA p < 0.001 for all transcripts) but does not significantly inhibits m7G-Cap methylation. Mean ± SEM, n = 3 biological replicates. No consistent effect of
time or interaction was found.
(B) DAA causes nuclear retention of de novo labeled RNA. Labeling was stopped at time 0 hr, coincidental with the start of DAA treatment (100 mM). Repre-
sentative pictures of Alexa 594 (red) andHoechst counterstaining (blue). Note the diffuse cytoplasmic labeling at 4 hr only in CTL-treated cells. Lower graph shows
mean intensity of 5 nuclei (±SEM); ***p < 0.001 in two-way ANOVA/Bonferroni.
(legend continued on next page)
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PER2::LUC MEFs with DAA and/or sub-saturating dose of acti-
nomycin D and recorded luminescence (Figure S3C). As previ-
ously reported, mild inhibition of transcription with a low dose
of actinomycin D caused circadian period shortening (Dibner
et al., 2009). DAA treatment led to opposite results, and cotreat-
ment with both agents showed additive negative effects.
Normalization and alignment of traces revealed that DAA and
actinomycin D both caused acceleration of the increasing phase
of Per2, but their effects became opposite during the waning
phase (Figure S3D). Taken together, these results show that
while DAA can act like a transcription elongation inhibitor, which
at least partly explains the decrease in pre-mRNA observed
above, its period elongating effect is the dominating component
and coincides with Per2 mRNA processing.
Next, we investigated the half-life of Per2::luc mRNA by real-
time luminescence assay. PER2::LUC MEFs were first treated
with dexamethasone for 2 hr to induce high Per2::luc expression,
then cells were treated with saturating levels of actinomycin
D (5 mM), and luminescence was acquired every 10 min. The
results, a significant delay in the half-life of PER2::LUC lumines-
cence, confirmed by direct quantification of Per2 mRNA, further
indicate delayed RNA processing (Figure 4D). Using the transla-
tion inhibitor cycloheximide instead of actinomycin D (Figure 4E)
confirms DAA does not affect PER2::LUC protein half-life but
only that of its mRNA. We next analyzed the half-life of 20
clock-related transcripts and housekeeping genes in U2OS
cells treated with actinomycin D with or without DAA, showing
that the DAA-dependent stabilization of transcripts is wide-
spread but specific to a subset of genes, with Arntl, Tef,
Nr1d2, and Per3 among the most affected (Figure S4). Together
our data suggest delayed mRNA processing leads to period
elongation, as was previously predicted by mathematical
modeling (Wilkins et al., 2007).
Knockdown and Overexpression of Mettl3 Have
Opposite Consequences on the Circadian Period
The data so far suggest the period elongation depends on the in-
hibition ofm6ARNA-methylation-dependent processing byDAA.
To specifically inhibit m6A methylation, we knocked down the
expression ofMettl3, the SAM-binding subunit of the only known
N6-Adenosine-methyltransferase. First confirming the reduction
of METTL3 proteins, knockdown of Mettl3 with either of two
different siRNA led to the elongation of the circadian period in
both U2OS and MEFs (Figures 5A and 5B). Waveform analysis
in PER2::LUC MEFs once more revealed asymmetric period
elongation, with a pronounced delay only observed during the
waning phase ofPer2 that closelymimics the effects of DAA (Fig-
ures S5A and S5B). In contrast to DAA, however, specific m6A
inhibition did not cause observable changes during the rising(C) Quantification ofArntl andPer2mRNA in nuclear and cytoplasmic fractions of C
of each fraction to total cellular mRNA (100%), all comparisons in two-way ANO
(D) PER2::LUC MEFs were stimulated by dexamethasone for 2 hr, then with 5 m
Curves were analyzed by one phase decay exponential fitting and comparing the
experiment but Per2mRNA was quantified every 30 min by real-time PCR. Data a
*p < 0.05; **p < 0.01; ***p < 0.001.
(E) Same as D, but using 350 mM cycloheximide (CHX) instead of ActinoD. K wa
See also Figures S3 and S4, and Table S2.phase, suggesting a mechanism other than m6A methylation
accelerates the increase of Per2 under DAA treatment. No dele-
terious effects caused by Mettl3 knockdown were observed on
either cell types (Figure S6B), as also confirmed by harmonious
and stable oscillations with a comparable baseline.
U2OS cells are known for the responsiveness to siRNA-medi-
ated knockdown (Zhang et al., 2009).We showedU2OS cells are
indeed exquisitely sensitive to Mettl3 knockdown compared to
MEFs, showing a 3-hr-period elongation with only 100 pmol of
siRNA#48. We then sought to maximize knockdown efficiency
in these cells. U2OS cells were transfected with 100 or 250
pmol of siRNA control or #48 and the period was analyzed,
showing a proportional increase of period with rising siRNA
#48 concentrations (Figure 5C). In addition, the m6A-methyl-
ated/unmethylated ratio of Arntl transcript was quantified as
a marker for functional knockdown (Figure 5C), revealing m6A
inhibition by Mettl3 knockdown causes exponential period
elongation.
To investigate the possibility that Mettl3 overexpression
instead leads to period shortening, U2OS Arntl-luc cells were
stably transfected with an expression vector for wild-type
hMettl3 or a mutated version (Mettl3D) bearing D394A and
W397A mutations. These mutations are within the universally
conserved catalytic motif IV of METTL3, known to severely blunt
m6A methylase activity in Saccharomyces (Bujnicki et al., 2002;
Clancy et al., 2002). Expression of the respectiveMettl3was first
confirmed by sequencing on cDNA isolated from each colony
(Figure S5C). As hypothesized, clones expressing the wild-type
form showed shorter period length than the control cells
expressing Mettl3D (Figure 5D).
Knockdown of Mettl3 Leads to RNA Processing Delay
Can slow m6A-dependent RNA processing cause a slow clock?
We tested this hypothesis by first showing that global RNA pro-
cessing was affected byMettl3 silencing. RNA labeling by pulse-
chase click cytochemistry revealed a delay in the loss of nuclear
RNA label in PER2::LUC MEFs transfected with siRNA#48
compared to control, as was observed with DAA (Figure 6A).
Silencing of Mettl3 caused a delay in nuclear label decay even
in the presence of actinomycin D to block transcriptional elonga-
tion, directly demonstrating slow RNA processing underlies the
results observed (Figure S7). Similar results were obtained in
U2OS cells (not shown).
Next, to show the impact of such a slow processing on clock
gene expression, Arntl and Per2 were quantified, in the nuclear
and cytoplasmic fractions of U2OS cells transfected with 250
pmol of siRNA #48 or control (maximal silencing conditions),
every 4 hr for 36 hr (Figure 6B). The results reveal that Mettl3
knockdown causes a delay in the exit of mature mRNA fromTL/DAA-treated cells after 0, 2, and 4 hr. Bar height represents the contribution
VA/Bonferroni; **p < 0.01; ***p < 0.001; mean ± SD, n = 2.
M actinomycin D ± 100 mM DAA immediately before starting measurements.
best fit value for the rate constant K by F test (n = 2). Right graph shows similar
nalyzed by two-way ANOVA/Bonferroni, mean ± SEM, n = 3. CTL versus DAA,
s not significant.
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Figure 5. Specific Inhibition of m6A-RNA Methylation Elongates the Circadian Period
(A and B):Mettl3 knockdown (two different siRNA, #48 and #49) causes period elongation in Arntl-luc U2OS cells (A) and in (B) PER2::LUC MEFs. Traces show
mean of n = 2 dishes. Left insert shows period, mean ± SD of n = 2 dishes, analyzed by one-way ANOVA/Bonferroni post hoc, all significance levels at least
p < 0.05. On the top of each graph, knockdown of METTL3 was confirmed for each cell type.
(C) Increasing the concentration of siRNA#48 dose dependently elongates the circadian period in U2OS cells. The insert shows period analyzed in one-way
ANOVA/Bonferroni, all comparison at least p < 0.01, mean ± SD, n = 2. Right upper graph shows decreased m6A methylation of Arntl transcript under CTL or
knockdown conditions, analyzed in one-way ANOVA/Bonferroni, all significant comparison at least p < 0.01, mean ± SD, n = 2 biological replicates. Lower right
graph shows exponential period elongation when m6A is progressively inhibited.
(D) Overexpression of wild-type METTL3 cause shorter period compared to control conditions when METTL3 is mutated and inactive (D). For each colony
isolated, top inserts show quantification of totalMettl3 expression by real-time PCR (expression in nontransfected cells = 1, mean ± SD, n = 2), and detection of
native and cloned (myc-flag tagged) METTL3. Right insert shows period analyzed by one-way ANOVA, all comparisons at least p < 0.05, mean ± SD, n = 2 for
each colony. See also Figures S5 and S6, and Table S2.the nucleus, detectable at the troughs of both Per2 and Arntl
transcripts. For Arntl, a normal processing delay of about 4 hr
is seen between nuclear steady-state pre-mRNA and cyto-
plasmic mRNA, but peak cytoplasmic mRNA is further delayed
around 4 hr in Mettl3 knockdown cells. Together these results
demonstrate that the lack of m6A-RNA methylation causes
a delay in RNA processing, affecting clock gene expression
dynamics.800 Cell 155, 793–806, November 7, 2013 ª2013 Elsevier Inc.Cap Methylation and Cap Binding Complex Also
Regulate the Circadian Period
While the role of m6A-RNA methylation in splicing, mRNA export
and translation remains to be clarified, that of 50 cap methylation
and subsequent binding of the Cap-binding complex (CBC) has
been extensively studied (Carmody and Wente, 2009). If m6A-
RNA-methylation-dependent processing is critical for the circa-
dian clock, we surmise that knockdown of either the m7G-Cap
Figure 6. Specific Inhibition of m6A-RNA
Methylation Delays mRNA Export and Affects
Clock Gene Dynamics
(A) Mettl3 knockdown by siRNA#48 leads to overall
RNA nuclear retention. Representative pictures of
Alexa 594 (red) and corresponding Hoechst coun-
terstaining (blue), graph on the right shows relative
mean intensity (0 hr = 100 for both CTL and
siRNA#48) of five nuclei (±SEM) analyzed by two-
way ANOVA/Bonferroni, **p < 0.01, ***p < 0.001.
(B) Mettl3 knockdown by siRNA#48 causes
increased time-lag between Arntl pre-mRNA and
maturemRNA in the cytoplasm, and increased time-
lag between nuclear and cytoplasmic mature Arntl
and Per2 mRNA. Notice the synchronous peak and
trough times for nuclear and cytoplasmic mRNA for
both Arntl and Per2 in CTL cells, but trough cyto-
plasmic mRNA is delayed in knockdown conditions.
For Arntl, notice the 4 hr-delay between peak pre-
mRNA and mRNA in CTL cells, becoming 4 hr in
knockdown conditions. Data show mean ± SEM
of n = 3 replicate dishes. See also Figure S7 and
Table S2.methylase Rnmt or the main CBC subunit Ncbp1 would also
elongate the circadian period. We first confirmed knockdown
of RNMT and NCBP1 proteins (Figure 7A), then demonstrate
that silencing of either of these proteins causes a delay in the
nuclear RNA labeling decay in a manner similar to that of Mettl3
(Figure 7B). Rnmt or Ncbp1 silencing led to the circadian period
elongation (Figures 7C and 7D), and cosilencing of Mettl3 with
Rnmt to inhibit both m6A and m7G-cap methylation revealed
additive effects on circadian period length, indicating nonre-
dundant mechanisms (Figure 7E). These results confirm our con-
clusions made in the previous sections that the circadian clock,
composed of a transcription-translation negative feedbackCell 155, 793–806loop, is exquisitely sensitive to perturba-
tions in RNA-methylation-dependent RNA
processing. Based on our results, we
propose RNA methylation regulates a sig-
nificant portion of the circadian transcrip-
tion-translation feedback loop (Figure 7F).
DISCUSSION
Here, we established the importance
of RNA methylation for the function of the
biological clock. More work is needed:
while m6A appears RNA sequence spe-
cific, m7G-Cap is thought to be ubiquitous,
and how these methylations are regulated
is unclear. The c-Myc proto-oncogene
can regulate the formation of m7G-Cap
on many mRNAs (Cowling, 2010), and
while it is clear m7G-Cap is necessary
for nuclear export and translation, we do
not know howgene expression is regulated
by induced m7G-Cap. Interestingly, c-Myc
is an E box (50-CANNTG-30)-binding factor
like CLOCK:ARNTL that drives circadian transcription. Whether
m7G-Cap induction is common to all E-box-binding factor or
only to c-Myc remains to be investigated. Similarly, the physio-
logical function of N6-Methyl-20-O-methyladenosine methylation
of the cap, which is also sensitive to methyl cycle inhibition
(Backlund et al., 1986), is unknown, as a reminder that the field
of RNA methylation is still in its infancy.
Histone methylation is circadian and modulates circadian
transcription (Katada and Sassone-Corsi, 2010; Valekunja
et al., 2013; Vollmers et al., 2012) but has not been linked to
the circadian period in mammals. As a control, we have investi-
gated whether DAA treatment also inhibits histone methylation, November 7, 2013 ª2013 Elsevier Inc. 801
Figure 7. m7G-cap Methylation and the Cap
Binding Complex Are Also Required for
Clock Function
(A) Effective knockdown of RNMT or NCBP1 pro-
teins in Arntl-luc U2OS cells (100 pmol siRNA/dish).
B: Rnmt (#831) or Ncbp1 (#976) silencing leads to
the retention of RNA in the nucleus of Arntl-luc
U2OS cells. To prevent de novo transcription during
chase, 5 mM actinomycin D was included in the
culture medium. Representative pictures of Alexa
594 (red) and corresponding Hoechst counter-
staining (blue), graph on the right shows relative
mean intensity (0 hr = 1 for CTL,Rnmt andNcbp1) of
10 nuclei (±SEM) analyzed by two-way ANOVA/
Bonferroni, *p < 0.05 **p < 0.01.
(C) Rnmt knockdown causes period elongation in
Arntl-luc U2OS cells. Insert shows period, mean ±
SD of n = 2 replicate traces, analyzed by one-way
ANOVA/Bonferroni post hoc, all significance levels
at least p < 0.05.
(D) Ncbp1 knockdown causes period elongation in
Arntl-luc U2OS cells. Insert shows period, mean ±
SD of n = 2 replicate traces, analyzed by one-way
ANOVA/Bonferroni post hoc, all significance levels
at least p < 0.001.
(E) Additive effects of Mettl3 and Rnmt cosilencing
on circadian period elongation (70 pmol/dish siRNA
each, 140 pmol total siRNA for each combination).
Left insert shows period, mean ± SD of n = 2 repli-
cate traces, analyzed by one-way ANOVA/Bonfer-
roni post hoc, all significance levels at least p < 0.01.
(F) We propose a model in which the circadian
cycle, containing processes such as splicing,
mRNA nuclear export and translation, is modulated
by RNA methylation. It remains unclear whether
m6A methylation only occurs at the pre-mRNA level
or m6A methylation-demethylation cycles can
happen at the mRNA level. See also Figure S6.
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and show that lysine methylation of histone H1, H2, and H3,
as well as H3K4-trimethylation are all inhibited (Figure S1F).
We confirmed Mettl3 silencing did not inhibit histone methyl-
ation, however (Figure S5D). While histone methylation is out
of the scope of the present paper, it may be possible that
histone methylation inhibition by DAA contribute to the effects
of DAA, especially the cell-type-specific changes in amplitude
observed.
While we have demonstrated that nuclear export and stability
of clock gene mRNA was affected in our studies, precisely what
aspect(s) of RNA-methylation-dependent processing cause(s)
period elongation remains unclear since splicing, mRNA export,
and stability, 30-end cleavage, polyadenylation, and translation
are all interdependent. Tentatively, we tested the splicing inhib-
itor spliceostatin A (Kaida et al., 2007) on PER2::LUCMEFs. Spli-
ceostatin A somewhat modified PER2::LUC oscillations, but the
period did not change significantly, suggesting splicing inhibition
per se does not control circadian period (Figure S6A).
Virtually all transmethylations rely on the availability of the uni-
versal methyl donor cosubstrate SAM, and the relative amount of
SAH that acts as a competitive inhibitor. Cyclic abundance of
these two metabolites has been described (Eckel-Mahan et al.,
2012; Schalinske and Steele, 1992), which may rhythmically
regulate transmethylations (histone and other substrates) within
the cell at the metabolic level. In particular, circadian RNA
methylation driving gene expression rhythms when de novo
transcription is not would provide an elegant explanation to the
observations made by Koike and coworkers (Koike et al.,
2012). Recently, two m6A demethylases were identified (Jia
et al., 2011; Zheng et al., 2013), supporting the possibility of
dynamically regulated m6A methylation.
We have demonstrated the presence of methylation sites
within many clock gene transcripts. Using unfragmented RNA
for immunoprecipitation, a method usually used with these
anti-methyl-RNA antibodies (Cole and Cowling, 2009; Fernan-
dez-Sanchez et al., 2009), we confirmed these observations.
Although the indiscriminate inhibition of m6A methylation, by
DAA or Mettl3 knockdown, led to circadian period elongation,
it would be interesting to investigate specifically which m6A
site, within which clock gene transcript, is sufficient for period
elongation. For this matter, Figure 3F provides an interesting
insight: some clock genes are among the most inhibited tran-
scripts in our data set. In the canonical circadian clock model
based on Drosophila work, PER proteins are the main state vari-
ables (Rosbash, 1995), also in mammals (Chen et al., 2009).
Indeed, a networkmodel of the circadian clock already predicted
that all processes reducing the half-life of Per2mRNA, including
faster mRNA degradation and faster mRNA export, would lead
to a shortened period, and slower mRNA export would lead to
longer period (Wilkins et al., 2007). Delaying nuclear import of
PER2 proteins by deleting its nuclear localization site leads
to longer circadian period (Miyazaki et al., 2007), suggesting de-
layed nuclear export of Per2 mRNA may have the same conse-
quences. When our data are seen together, however, it appears
that Arntl is very sensitive to DAA treatment or Mettl3 silencing,
more so than Per2, with clear nuclear accumulation (Figure 4C),
more pronounced delays in transcripts processing (Figure 6B),
and markedly elongated half-life (Figure S4), suggesting Arntlmay contribute to the period elongation observed. Future work
should clarify this issue.
In conclusion, we have established the importance of RNA
methylation for the functionof thecircadian clock. Thispioneering
work provides many potential avenues for further investigations.
EXPERIMENTAL PROCEDURES
Reagents
All chemicals were obtained from Nacalai-Tesque (Japan) unless otherwise
stated.
Real-Time Luciferase Assays, Drug Treatment, and Transfection
Cells were plated at around 50% density and allowed to grow for at least
3 days in phenol-red free standard medium. Cells were then synchronized
by a medium change, with 200 nM dexamethasone (Sigma-Aldrich) for 2 hr.
Medium was then replaced with new medium containing 1 mM luciferine
and luminescence was recorded in a luminometer-incubator at 37C (Kronos
DIO, ATTO) in successive bins of 20 min. DAA (Sigma-Aldrich) or vehicle was
added to the medium at the appropriate time.
For siRNA transfection, U2OS (stably transfected with Arntl-luc reporter) or
MEF cells were plated in standard medium. The next day, medium was
changed, all antibiotics omitted. Invitrogen Stealth siRNA against human
Mettl3 (#48 and #49), Rnmt (#831 and #832), Ncbp1 (#976 and #445), or nega-
tive controls of similar GC%were complexedwith Lipofectamine 2000 (Invitro-
gen) following manufacturer’s protocol. For the control in cosilencing of Rnmt
and Mettl3, a 1:1 mix of two different negative controls siRNA was used.
Medium was replaced 6 to 8 hr after transfection. Two days later, cells were
synchronized with 200 nM dexamethasone. After 2 hr, medium was replaced
with medium containing 1 mM luciferine. Luminescence was recorded in suc-
cessive bins of 20 min at 37C. Period estimates from luminescence traces
were obtained using BRASS (Plautz et al., 1997). Luminescence traces from
U2OS Arntl-luc cells were first detrended (subtract a 24-hr-moving average)
in order to obtain a more stable baseline before period estimation. Figure S5A
illustrates this process. The impact of the silencing of every gene tested here
on cell viability and proliferation was briefly assessed before downstream
experiments by taking phase-contrast representative pictures of correspond-
ing cell populations (Figure S6B).
For stable transfection of U2OS Arntl-luc cells, cells were transfected with
Origene TrueORF hMettl3 vector or the mutated version (obtained by standard
PCR) using Lipofectamine 2000 following manufacturer’s protocol. Twenty-
four hours after transfection medium was changed, adding 1 mg/ml G418
for Neomycin selection, and cells were incubated until colonies had formed.
Untransfected cells showed 100% mortality. Colonies were picked and
passaged in 35 mm Petri dishes and allowed to grow to confluence in
phenol-red free DMEM/F12 containing charcoal-stripped FBS and 1 mg/ml
G418 (kept in medium therefater). At confluence, cells were treated 2 hr with
200 nM dexamethasone and luminescence was measured as described
above. Circadian period of colonies was confirmed after two additional
passages.
Per1-luc SCN Slices Culture
Slices were prepared according to our standard method (Yamaguchi et al.,
2000).
Animals and Brain DAA Infusion
All experiments were approved by the animal experimentation committee
of Kyoto University. C57/BL6 males were maintained at 23C ± 1C with
50% ± 10% relative humidity, one animal per cage on a 12 hr light/12 hr
dark cycle (lights on 8:00, lights off 20:00), food and water ad libitum. DAA
was continuously delivered to the SCN via osmotic pump as described (Doi
et al., 2011). In brief, the infusion cannula (Alzet, Brain Infusion Kit 2) was
directed stereotaxically to the SCN; the osmotic pump (Alzet, pump model
1002) containing 10 mM DAA (58 nmol/day) was implanted subcutaneously
(dorsal skin) by surgery under anesthesia. After surgery, animals were returned
to their home cages and maintained under constant darkness.Cell 155, 793–806, November 7, 2013 ª2013 Elsevier Inc. 803
LCMS-IT-TOF Protocol
The amount ofmetaboliteswasmeasured by LCMS-IT-TOF (Shimadzu, Japan).
LC separation was performed on a ZIC-HILIC column (Merck Millipore, Ger-
many; 2.13 150 mm, 3.5 mm) at 40C. MeCN/H2O/formic acid (1:98:1) (A) and
MeCN/H2O/formic acid (98:1:1) (B) were used as the mobile phase, with a
gradient elution system: 95% B for 1 min, shifted to 10% B in 9 min, and kept
10%B for 2min. The systemwas allowed to equilibrate for 10minat 95%Bprior
to the next analysis. The flow rate was 100 ml/min. Ten microliters metabolite
extractwasanalyzedand thepeakareasof themetabolitesdetected inapositive
ion mode were normalized by the peak areas of the internal standard, Bis-Tris.
Me-RIP-Seq
Total RNA was extracted from cells treated with deazaadenosine (100 mM) or
vehicle for 24 hr, n = 3. mRNA samples were purified from 200 microg total
RNA by two rounds of Oligotex-dT30 (Takara, Japan). All mRNA samples
were analyzed by Bioanalyzer to check for mRNA quality. mRNA was then
fragmented using NEBNext Fragmentation Magnesium buffer (NEB Japan)
then purified with RNA Minelute column (QIAGEN, Japan). All fragmented
mRNA samples were analyzed by Bioanalyzer to confirm a major population
of 200 bp RNA fragments; 500 ng fragmented mRNA from each sample
was immunoprecipitated using the anti-m6A antibody, then extracted
following the procedure explained below.
Sequencing librarieswerepreparedusing theNEBNextUltraRNALibraryPrep
Kitwithpartiallymodifiedsteps in randomprimer annealingconditionas65C for
15 min, and sequencing was performed on an Illumina Genome Analyzer IIx.
Reads were mapped to the human genome (hg19 from UCSC genome
browser database) using TopHat v2.0.0 (Trapnell et al., 2009). Only reads
that had a Phred quality score R 25 were analyzed. For filtering rRNA and
tRNA, BEDtools package (Quinlan and Hall, 2010) was used with rRNA and
tRNA annotations downloaded from UCSC table browser was used.
For evaluating differentially expression between DAA- and CTL-treated
U2OS cells, EdgeR (Robinson and Smyth, 2007) was used for statistical testing
using trimmed mean of M-values (TMM) method for normalization and
generating P-values on Genomatix Genome Analyzer (Genomatix, Munich,
Germany). For identification and quantification of Me-RIP regions, each value
obtained with Me-RIP sample was background-subtracted with correspond-
ing values in the input samples. Only transcripts with #reads > 50 were
included in the analysis. Input and Me-RIP data are available in the GEO
repository under accession number GSE48037.
Normalized expression value (NE-value) is calculated based on the following
formula:
NE = 107 * the number of readsregion/(the number of readsmapped *
lengthregion) (Audic and Claverie, 1997).
GO Enrichment Analysis
Transcripts with p value > 0.05, then with #reads < 100 in CTL samples were
discarded. GO enrichment analysis was carried out with single gene IDs using
GOrilla (Eden et al., 2007; Eden et al., 2009), either using a single ranked list of
genes or using two unranked lists (target and background). Redundant GO hits
were filtered using REVIGO.
RNA Immunoprecipitation
RNA was first extracted using a combination of Sepasol RNA I super G and
RNeasy (QIAGEN, Japan) following RNeasy protocol for Lipid tissues with
Sepasol instead of Qiazol. Next, 1.5 mg of RNA or 500 ng fragmented mRNA
was incubated in 250 ml of 20% protein A- or G-Agarose slurry in IPP buffer
for 1 hr at 4C for background removal. The RNA/beads slurry was then centri-
fuged at 7003 g, 4C for 2 min, the RNA supernatant (200 ml) was used in the
next step and the agarose beads pellet discarded.
Fifty percent proteinG- or A-Agarose slurry in IPPbufferwas conjugatedwith
anti-m7G-capmousemonoclonal antibody (SynapticSystems, 80ml ascites/ml
slurry) or anti-m6A rabbit polyclonal antibody (Synaptic Systems, 30 mg
antibody/ml slurry) for 3 hr at 4C, respectively. Beads were then washed
by five cycles of re-suspension with >2 volumes of buffer, then centrifugation
(700 3 g, 4C for 2 min). The final 50% beads-antibody conjugate slurry
was then aliquoted into 1.5 ml tubes, 100 ml/tubes; tubes were centrifuged
at 700 3 g, 4C for 2 min and beads (50 ml) were resuspended with the RNA804 Cell 155, 793–806, November 7, 2013 ª2013 Elsevier Inc.supernatant from the previous step and incubated at 4C overnight in a tube
rotator, with 0.5 mM random decamers (Invitrogen, Japan) in IPP buffer as
blocking reagent. The tubes were then centrifuged at 700 3 g, 4C for 2 min;
supernatant (unmethylated RNA) was transferred to a new tube, brought to
250ml with the samebuffer, and homogenizedwith 750 ml Sepasol RNA II Super
by vortexing at full speed then kept at 80C until processed further. Pellet
(methylated RNA) were washed by five cycles of resuspension with at least
10 volumes of IPP buffer and centrifugation at 7003 g, 4C for 2 min. The final
pellet (50 ml) was homogenized with 1ml Sepasol RNA I super G by vortexing
at full speed then kept at 80C until processed further. Total RNA from the
supernatant and pellet fractions was extracted with a combination of Qiazol/
RNeasy micro kit following QIAGEN protocol, with Sepasol instead of Qiazol.
The RNA eluate (14 ml) was then used for RNA quantification by Nanodrop
and reverse-transcribed usingVILO. The specificity of our immunoprecipitation
procedure on unfragmented RNA is demonstrated in Figure S3E.
Quantitative Real-Time PCR
Quantitative real-time PCR was performed using Platinum SYBR Green (Invi-
trogen) in StepOnePlus (Applied Biosystems, Tokyo, Japan). Quantification
standards for each target cDNA were obtained using band-purified PCR prod-
ucts as templates. Data were normalized using relative expression of the
housekeeping gene 36b4, which was found unaffected by either DAA treat-
ment or Mettl3 knockdown. Primer sequences given Table S2.
Western Blot
Cells were lysed directly with 300 ml 23 Laemmli buffer and boiled at 95C for
10 min, then centrifuged at 14,000 g, 4C for 10 min. Standard western blot
procedures were performed using reagents from ATTO. Blotting membranes
were revealed with ECL-prime (GE Healthcare) and visualized using a digital
imaging system (LAS4000, Fujifilm).
Pulse-Chase Click RNA Cytochemistry
The Click-iT RNA Alexa Fluor 594 Imaging Kit was used according tomanufac-
turer’s protocol (Invitrogen). Cells were incubated for 2 hr with 1.5 mM ethynyl
uridine and 200 nM dexamethasone for simultaneous synchronization, then
medium was replaced with medium containing 0 or 100 mM DAA. Cells were
fixed at the indicated chase time. For pulse-chase of siRNA-transfected cells,
the labeling was also performed for 2 hr, simultaneously with dexamethasone
shock, and terminated upon medium replacement.
Cellular Fractionation
Cells cultivated in 6-well plates were washed once in the dish with ice-cold
PBS, 1 mM EDTA, then scraped on ice with 250 ml homogenization buffer
(HB) at 4C. Cells were transferred to a precooled 1.5 ml tube and cell walls
were disrupted using 10 passages with a 25G needle, on ice. Cells were centri-
fuged at 700 3 g for 10 min at 4C, the supernatant (containing cytoplasmic
RNA) carefully removed and transferred to a new tube on ice, its volume
brought up to250ml withHBand immediately homogenizedwith 750ml Sepasol
RNA II Super by full-speed vortexing. The pellet was resuspended in 50 ml HB
and layered on top of a 24%sucrose cushion HB. Nuclei were then centrifuged
at 20,0003g for 10min at 4C. The supernatantwasdiscarded andnuclei were
homogenized in 1ml Sepasol RNA I Super Gby full-speed vortexing, then incu-
bated at 65C, vortexing frequently until fully homogenized. RNA was then
extracted, retro-transcribed and quantified following standard procedures.
Statistical Analyses
Statistical analyses and plots were performed with GraphPad prism 5, using
statistical test proper for each figure, as indicated. Period estimates from all
luminescence traces were obtained using BRASS on normalized data (Plautz
et al., 1997).
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